カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のタフェノキン市場2022年：粉末、丸薬

◆英語タイトル：Global Tafenoquine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8972 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：97 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

タフェノキン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のタフェノキンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

タフェノキン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・粉末、丸薬

用途別セグメントは次のように区分されます。
・三日熱マラリア原虫根治、熱帯熱マラリア原虫治療、マラリア再発予防

世界のタフェノキン市場の主要な市場プレーヤーは以下のとおりです。
・GlaxoSmithKline Pharmaceuticals (GSK)、J & K Scientific LTD、BOC Sciences、WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.、Pharmacodia (Beijing) Co.,Ltd、Amadis Chemical Company Limited、Merck

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、タフェノキン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なタフェノキンメーカーの企業概要、2019年～2022年までのタフェノキンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なタフェノキンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別タフェノキンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのタフェノキンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのタフェノキン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびタフェノキンの産業チェーンを掲載しています。
・第13、14、15章では、タフェノキンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline Pharmaceuticals (GSK)、J & K Scientific LTD、BOC Sciences、WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.、Pharmacodia (Beijing) Co.,Ltd、Amadis Chemical Company Limited、Merck
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：粉末、丸薬
・用途別分析2017年-2028年：三日熱マラリア原虫根治、熱帯熱マラリア原虫治療、マラリア再発予防
・タフェノキンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・タフェノキンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・タフェノキンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・タフェノキンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・タフェノキンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Tafenoquine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tafenoquine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Radical Cure of P.vivax accounting for % of the Tafenoquine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Powder segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tafenoquine include GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., and Pharmacodia (Beijing) Co.,Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tafenoquine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Powder
Pills
Market segment by Application can be divided into
Radical Cure of P.vivax
P. falciparum Treatment
Prevention of Malaria Relapse
The key market players for global Tafenoquine market are listed below:
GlaxoSmithKline Pharmaceuticals (GSK)
J & K Scientific LTD
BOC Sciences
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Pharmacodia (Beijing) Co.,Ltd
Amadis Chemical Company Limited
Merck
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tafenoquine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tafenoquine, with price, sales, revenue and global market share of Tafenoquine from 2019 to 2022.
Chapter 3, the Tafenoquine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tafenoquine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tafenoquine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tafenoquine.
Chapter 13, 14, and 15, to describe Tafenoquine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Tafenoquine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tafenoquine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Powder
1.2.3 Pills
1.3 Market Analysis by Application
1.3.1 Overview: Global Tafenoquine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Radical Cure of P.vivax
1.3.3 P. falciparum Treatment
1.3.4 Prevention of Malaria Relapse
1.4 Global Tafenoquine Market Size & Forecast
1.4.1 Global Tafenoquine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Tafenoquine Sales in Volume (2017-2028)
1.4.3 Global Tafenoquine Price (2017-2028)
1.5 Global Tafenoquine Production Capacity Analysis
1.5.1 Global Tafenoquine Total Production Capacity (2017-2028)
1.5.2 Global Tafenoquine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tafenoquine Market Drivers
1.6.2 Tafenoquine Market Restraints
1.6.3 Tafenoquine Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline Pharmaceuticals (GSK)
2.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Details
2.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Major Business
2.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product and Services
2.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 J & K Scientific LTD
2.2.1 J & K Scientific LTD Details
2.2.2 J & K Scientific LTD Major Business
2.2.3 J & K Scientific LTD Tafenoquine Product and Services
2.2.4 J & K Scientific LTD Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BOC Sciences
2.3.1 BOC Sciences Details
2.3.2 BOC Sciences Major Business
2.3.3 BOC Sciences Tafenoquine Product and Services
2.3.4 BOC Sciences Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
2.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Details
2.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Major Business
2.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product and Services
2.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pharmacodia (Beijing) Co.,Ltd
2.5.1 Pharmacodia (Beijing) Co.,Ltd Details
2.5.2 Pharmacodia (Beijing) Co.,Ltd Major Business
2.5.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product and Services
2.5.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Amadis Chemical Company Limited
2.6.1 Amadis Chemical Company Limited Details
2.6.2 Amadis Chemical Company Limited Major Business
2.6.3 Amadis Chemical Company Limited Tafenoquine Product and Services
2.6.4 Amadis Chemical Company Limited Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Tafenoquine Product and Services
2.7.4 Merck Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Tafenoquine Breakdown Data by Manufacturer
3.1 Global Tafenoquine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Tafenoquine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Tafenoquine
3.4 Market Concentration Rate
3.4.1 Top 3 Tafenoquine Manufacturer Market Share in 2021
3.4.2 Top 6 Tafenoquine Manufacturer Market Share in 2021
3.5 Global Tafenoquine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Tafenoquine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tafenoquine Market Size by Region
4.1.1 Global Tafenoquine Sales in Volume by Region (2017-2028)
4.1.2 Global Tafenoquine Revenue by Region (2017-2028)
4.2 North America Tafenoquine Revenue (2017-2028)
4.3 Europe Tafenoquine Revenue (2017-2028)
4.4 Asia-Pacific Tafenoquine Revenue (2017-2028)
4.5 South America Tafenoquine Revenue (2017-2028)
4.6 Middle East and Africa Tafenoquine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Tafenoquine Sales in Volume by Type (2017-2028)
5.2 Global Tafenoquine Revenue by Type (2017-2028)
5.3 Global Tafenoquine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Tafenoquine Sales in Volume by Application (2017-2028)
6.2 Global Tafenoquine Revenue by Application (2017-2028)
6.3 Global Tafenoquine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Tafenoquine Sales by Type (2017-2028)
7.2 North America Tafenoquine Sales by Application (2017-2028)
7.3 North America Tafenoquine Market Size by Country
7.3.1 North America Tafenoquine Sales in Volume by Country (2017-2028)
7.3.2 North America Tafenoquine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Tafenoquine Sales by Type (2017-2028)
8.2 Europe Tafenoquine Sales by Application (2017-2028)
8.3 Europe Tafenoquine Market Size by Country
8.3.1 Europe Tafenoquine Sales in Volume by Country (2017-2028)
8.3.2 Europe Tafenoquine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Tafenoquine Sales by Type (2017-2028)
9.2 Asia-Pacific Tafenoquine Sales by Application (2017-2028)
9.3 Asia-Pacific Tafenoquine Market Size by Region
9.3.1 Asia-Pacific Tafenoquine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Tafenoquine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Tafenoquine Sales by Type (2017-2028)
10.2 South America Tafenoquine Sales by Application (2017-2028)
10.3 South America Tafenoquine Market Size by Country
10.3.1 South America Tafenoquine Sales in Volume by Country (2017-2028)
10.3.2 South America Tafenoquine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tafenoquine Sales by Type (2017-2028)
11.2 Middle East & Africa Tafenoquine Sales by Application (2017-2028)
11.3 Middle East & Africa Tafenoquine Market Size by Country
11.3.1 Middle East & Africa Tafenoquine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Tafenoquine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Tafenoquine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Tafenoquine
12.3 Tafenoquine Production Process
12.4 Tafenoquine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Tafenoquine Typical Distributors
13.3 Tafenoquine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Tafenoquine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Tafenoquine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GlaxoSmithKline Pharmaceuticals (GSK) Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Pharmaceuticals (GSK) Major Business
Table 5. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product and Services
Table 6. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (Tons), Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. J & K Scientific LTD Basic Information, Manufacturing Base and Competitors
Table 8. J & K Scientific LTD Major Business
Table 9. J & K Scientific LTD Tafenoquine Product and Services
Table 10. J & K Scientific LTD Tafenoquine Sales (Tons), Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. BOC Sciences Basic Information, Manufacturing Base and Competitors
Table 12. BOC Sciences Major Business
Table 13. BOC Sciences Tafenoquine Product and Services
Table 14. BOC Sciences Tafenoquine Sales (Tons), Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 16. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Major Business
Table 17. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product and Services
Table 18. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (Tons), Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pharmacodia (Beijing) Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Pharmacodia (Beijing) Co.,Ltd Major Business
Table 21. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product and Services
Table 22. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (Tons), Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Amadis Chemical Company Limited Basic Information, Manufacturing Base and Competitors
Table 24. Amadis Chemical Company Limited Major Business
Table 25. Amadis Chemical Company Limited Tafenoquine Product and Services
Table 26. Amadis Chemical Company Limited Tafenoquine Sales (Tons), Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Basic Information, Manufacturing Base and Competitors
Table 28. Merck Major Business
Table 29. Merck Tafenoquine Product and Services
Table 30. Merck Tafenoquine Sales (Tons), Price (US$/Gram), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Tafenoquine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
Table 32. Global Tafenoquine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Tafenoquine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Tafenoquine Production Capacity by Company, (Tons): 2020 VS 2021
Table 35. Head Office and Tafenoquine Production Site of Key Manufacturer
Table 36. Tafenoquine New Entrant and Capacity Expansion Plans
Table 37. Tafenoquine Mergers & Acquisitions in the Past Five Years
Table 38. Global Tafenoquine Sales by Region (2017-2022) & (Tons)
Table 39. Global Tafenoquine Sales by Region (2023-2028) & (Tons)
Table 40. Global Tafenoquine Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Tafenoquine Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Tafenoquine Sales by Type (2017-2022) & (Tons)
Table 43. Global Tafenoquine Sales by Type (2023-2028) & (Tons)
Table 44. Global Tafenoquine Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Tafenoquine Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Tafenoquine Price by Type (2017-2022) & (US$/Gram)
Table 47. Global Tafenoquine Price by Type (2023-2028) & (US$/Gram)
Table 48. Global Tafenoquine Sales by Application (2017-2022) & (Tons)
Table 49. Global Tafenoquine Sales by Application (2023-2028) & (Tons)
Table 50. Global Tafenoquine Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Tafenoquine Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Tafenoquine Price by Application (2017-2022) & (US$/Gram)
Table 53. Global Tafenoquine Price by Application (2023-2028) & (US$/Gram)
Table 54. North America Tafenoquine Sales by Country (2017-2022) & (Tons)
Table 55. North America Tafenoquine Sales by Country (2023-2028) & (Tons)
Table 56. North America Tafenoquine Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Tafenoquine Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Tafenoquine Sales by Type (2017-2022) & (Tons)
Table 59. North America Tafenoquine Sales by Type (2023-2028) & (Tons)
Table 60. North America Tafenoquine Sales by Application (2017-2022) & (Tons)
Table 61. North America Tafenoquine Sales by Application (2023-2028) & (Tons)
Table 62. Europe Tafenoquine Sales by Country (2017-2022) & (Tons)
Table 63. Europe Tafenoquine Sales by Country (2023-2028) & (Tons)
Table 64. Europe Tafenoquine Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Tafenoquine Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Tafenoquine Sales by Type (2017-2022) & (Tons)
Table 67. Europe Tafenoquine Sales by Type (2023-2028) & (Tons)
Table 68. Europe Tafenoquine Sales by Application (2017-2022) & (Tons)
Table 69. Europe Tafenoquine Sales by Application (2023-2028) & (Tons)
Table 70. Asia-Pacific Tafenoquine Sales by Region (2017-2022) & (Tons)
Table 71. Asia-Pacific Tafenoquine Sales by Region (2023-2028) & (Tons)
Table 72. Asia-Pacific Tafenoquine Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Tafenoquine Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Tafenoquine Sales by Type (2017-2022) & (Tons)
Table 75. Asia-Pacific Tafenoquine Sales by Type (2023-2028) & (Tons)
Table 76. Asia-Pacific Tafenoquine Sales by Application (2017-2022) & (Tons)
Table 77. Asia-Pacific Tafenoquine Sales by Application (2023-2028) & (Tons)
Table 78. South America Tafenoquine Sales by Country (2017-2022) & (Tons)
Table 79. South America Tafenoquine Sales by Country (2023-2028) & (Tons)
Table 80. South America Tafenoquine Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Tafenoquine Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Tafenoquine Sales by Type (2017-2022) & (Tons)
Table 83. South America Tafenoquine Sales by Type (2023-2028) & (Tons)
Table 84. South America Tafenoquine Sales by Application (2017-2022) & (Tons)
Table 85. South America Tafenoquine Sales by Application (2023-2028) & (Tons)
Table 86. Middle East & Africa Tafenoquine Sales by Region (2017-2022) & (Tons)
Table 87. Middle East & Africa Tafenoquine Sales by Region (2023-2028) & (Tons)
Table 88. Middle East & Africa Tafenoquine Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Tafenoquine Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Tafenoquine Sales by Type (2017-2022) & (Tons)
Table 91. Middle East & Africa Tafenoquine Sales by Type (2023-2028) & (Tons)
Table 92. Middle East & Africa Tafenoquine Sales by Application (2017-2022) & (Tons)
Table 93. Middle East & Africa Tafenoquine Sales by Application (2023-2028) & (Tons)
Table 94. Tafenoquine Raw Material
Table 95. Key Manufacturers of Tafenoquine Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Tafenoquine Typical Distributors
Table 99. Tafenoquine Typical Customers
List of Figures
Figure 1. Tafenoquine Picture
Figure 2. Global Tafenoquine Revenue Market Share by Type in 2021
Figure 3. Powder
Figure 4. Pills
Figure 5. Global Tafenoquine Revenue Market Share by Application in 2021
Figure 6. Radical Cure of P.vivax
Figure 7. P. falciparum Treatment
Figure 8. Prevention of Malaria Relapse
Figure 9. Global Tafenoquine Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
Figure 10. Global Tafenoquine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Tafenoquine Sales (2017-2028) & (Tons)
Figure 12. Global Tafenoquine Price (2017-2028) & (US$/Gram)
Figure 13. Global Tafenoquine Production Capacity (2017-2028) & (Tons)
Figure 14. Global Tafenoquine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Tafenoquine Market Drivers
Figure 16. Tafenoquine Market Restraints
Figure 17. Tafenoquine Market Trends
Figure 18. Global Tafenoquine Sales Market Share by Manufacturer in 2021
Figure 19. Global Tafenoquine Revenue Market Share by Manufacturer in 2021
Figure 20. Tafenoquine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Tafenoquine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Tafenoquine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Tafenoquine Sales Market Share by Region (2017-2028)
Figure 24. Global Tafenoquine Revenue Market Share by Region (2017-2028)
Figure 25. North America Tafenoquine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Tafenoquine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Tafenoquine Revenue (2017-2028) & (USD Million)
Figure 28. South America Tafenoquine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Tafenoquine Revenue (2017-2028) & (USD Million)
Figure 30. Global Tafenoquine Sales Market Share by Type (2017-2028)
Figure 31. Global Tafenoquine Revenue Market Share by Type (2017-2028)
Figure 32. Global Tafenoquine Price by Type (2017-2028) & (US$/Gram)
Figure 33. Global Tafenoquine Sales Market Share by Application (2017-2028)
Figure 34. Global Tafenoquine Revenue Market Share by Application (2017-2028)
Figure 35. Global Tafenoquine Price by Application (2017-2028) & (US$/Gram)
Figure 36. North America Tafenoquine Sales Market Share by Type (2017-2028)
Figure 37. North America Tafenoquine Sales Market Share by Application (2017-2028)
Figure 38. North America Tafenoquine Sales Market Share by Country (2017-2028)
Figure 39. North America Tafenoquine Revenue Market Share by Country (2017-2028)
Figure 40. United States Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Tafenoquine Sales Market Share by Type (2017-2028)
Figure 44. Europe Tafenoquine Sales Market Share by Application (2017-2028)
Figure 45. Europe Tafenoquine Sales Market Share by Country (2017-2028)
Figure 46. Europe Tafenoquine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Tafenoquine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Tafenoquine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Tafenoquine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Tafenoquine Revenue Market Share by Region (2017-2028)
Figure 56. China Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Tafenoquine Sales Market Share by Type (2017-2028)
Figure 63. South America Tafenoquine Sales Market Share by Application (2017-2028)
Figure 64. South America Tafenoquine Sales Market Share by Country (2017-2028)
Figure 65. South America Tafenoquine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Tafenoquine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Tafenoquine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Tafenoquine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Tafenoquine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Tafenoquine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Tafenoquine in 2021
Figure 77. Manufacturing Process Analysis of Tafenoquine
Figure 78. Tafenoquine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のタフェノキン市場2022年：粉末、丸薬(Global Tafenoquine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のタフェノキン市場2022年：粉末、丸薬

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp